RxE2
PrivateLast Round
Seed
Oct 20, 2022
Total Funding Raised
$4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RxE2 is a healthcare technology company that provides a platform to integrate community pharmacists into clinical trials to enhance patient recruitment, adherence, and data quality.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxE2 Comparables
Compare RxE2 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curebase | 79% | |
| eMed | 77% | |
| ObvioHealth | 77% | |
RxE2 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 20, 2022 |
Key People
Founding team and executive leadership
RxE2 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| O'Leary Ventures | Seed |
| Badlands Capital | Seed |
| MATTER | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
Launched the "Pharm-to-Trial" model utilizing local pharmacies.
- Oct 10, 2025
Will be attending the NCPA 2025 event.
RxE2 Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RxE2's valuation, stock price, and market status.